We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Device Products » Brexit and the Impact to Your Global Business Operations - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Nov. 1, 2018

$287.00

Audio Recording/Transcript - Nov. 1, 2018

$258.00

Audio Recording/Transcript - Nov. 1, 2018

$244.00

Audio Recording/Transcript - Nov. 1, 2018

$230.00

Audio Recording/Transcript - Nov. 1, 2018

$215.00

Brexit and the Impact to Your Global Business Operations - Webinar Recording/Transcript

$287.00
Device Products

Product Details

Brexit and the Impact to Your Global Business Operations: What Life Sciences Companies Need to Know Now

Your international drug and device business is at a crossroads known as Brexit — the withdrawal of the United Kingdom (UK) from the European Union (EU).

What can you expect?

The EMA is moving to from London to Amsterdam in March 2019 — and will lose a 30 percent of its staff. The agency has already stopped accepting and publishing clinical trials data.

What about the legal uncertainty regarding contracts involving both the UK and other EU member states?

Brexit is about to happen and you need to make plans before it does. Prepare to discover:

  • The impact on international harmonization efforts — the EMA will “only take a reactive role,” focus on “urgent” drug safety guidelines and limit travel to “Brexit-related interactions.”
  • How to deal with the legal uncertainty introduced into contracts involving both the UK and EU member states
  • And much more…

Brexit will be finalized on March 29, 2019. You need to know how it will impact your global operations. Order today to minimize potential disruptions.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing